Brief: Ra Capital Management, L.P. Reports 9.99% Passive Stake In Gracell Biotechnologies - SEC Filing
Aug 21 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* RA CAPITAL MANAGEMENT, L.P. REPORTS 9.99% PASSIVE STAKE IN
GRACELL BIOTECHNOLOGIES INC. AS OF AUG 10 - SEC FILING
Source text for Eikon: ID:
Further company coverage: GRCL.O
(Reporting by Zaheer Kachwala)
((Zaheer.Kachwala@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27